EFFECTS OF LIGUSTRAZINE ON EARLY DIABETIC NEPHROPATHY
Xihua Wang
Abstract
Xihua Wang
Abstract
Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To observe the effects of Ligustrazine on early diabetic nephropathy(DN). Methods Sixty-two patients with early DN were randomly divided into control group (31 cases ,regular therapy) and treated group (31 cases ,regular therapy plus Ligustrazine). The course of treatment was 4 weeks. The glomerular filtration rate (GFR),urinary albumin excretion rate(UAER),blood and urine β 2-microglobulin(β 2-MG) were determined for both groups before and after the treatment, the side effects during the treatment were observed as well. Results Blood sugar, GFR, UAER, blood and urine β 2-MG were improved very much for the both groups after the treatment (t=2.917-5.126, P0.05), but the treated group was much better than that of the control group in terms of GFR, UAER and blood β 2-MG (t=2.105-2.864, P0.05). No obvious side effects were found by using Ligustrazine during the treatment. Conclusion Ligustrazine has a beneficial effect on early diabetic nephropathy.
Key concepts: Medicine, Diabetic nephropathy, Renal function, Urology, Excretion, Urine, Internal medicine, Beta-2 microglobulin